Status:
COMPLETED
Indocyanine Green Fluorescence-guided Sentinel Node Biopsy in Breast Cancer Within a North African Population: a Retrospective Study
Lead Sponsor:
Faculty of Medicine, Sousse
Conditions:
Breast Cancer
Sentinel Lymph Node
Eligibility:
FEMALE
20+ years
Brief Summary
Background Radio Isotopes and Blue dye alone or in combination are the most commonly used tracer agents in sentinel Node Biopsy for early breast cancer. Recent studies have found fluorescence method u...
Detailed Description
We performed a retrospective review our data base that includes breast cancer planned for sentinel node biopsy at the F. Hached University teaching hospital(Sousse, Tunisia). Data between April 2016 a...
Eligibility Criteria
Inclusion
- non-pregnant or lacting adult female patients with breast cancer without palpable clinical node and considered suitable for such procedure at multidisciplinary meeting were included
Exclusion
- Non eligible patient for breast cancer sentinel node procedure
Key Trial Info
Start Date :
April 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2021
Estimated Enrollment :
47 Patients enrolled
Trial Details
Trial ID
NCT04879680
Start Date
April 1 2016
End Date
April 1 2021
Last Update
May 10 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.